Long-term survival in childhood solid organ transplants
Paediatric solid organ transplant is a successful treatment for solid organ failure with prolonged graft and recipient survival over the past decade. Even though over 80 per cent of paediatric transplant recipients enjoy long-term survival into adolescence and adulthood, the risk of comorbid conditions increases over time given the very long-term exposure to transplant medications, primary end-organ disease and likely repeated transplants over their lifetime. We created a longitudinal paediatric Toronto transplant cohort study with up to 25 years of follow-up. We will create a data repository of information during transplant follow-up at The Hospital for Sick Children (SickKids) and link to available administrative databases at the Institute for Clinical Evaluative Sciences for over 1,000 children with a solid organ transplant performed at SickKids.
We aim to study:
- the absolute risk of diabetes, hypertension, CVD, CKD, malignancy, and mortality;
- the relative risk of outcomes to an age and sex-matched general population in Ontario; and
- the direction, magnitude and strength of association for modifiable risk factors and development of morbidities and mortality across organ groups.
The results from this study may be used as the basis of new clinical recommendations for screening children with a solid organ transplant, treatment and lifestyle modifications to minimize the risk of subsequent morbidity and mortality.